Purposeful Company

Discover alternative effects for existing drugs using its advanced computational workflow.

Investors

Industry: AI, End-to-end Drug Development
Headquarters: Athens, Attiki, Greece
Founded Date: 2018-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 1
Total Funding: 200000
Last Funding Date: 2018-10-18
Last Funding Type: Pre-Seed

Visit Website
Register and Claim Ownership